Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes

In This Article: In its second quarter 2025 investor letter, Oakmark Equity and Income Fund highlighted stocks such as Charles River Laboratories International, Inc. (NYSE:CRL). Charles River Laboratories International, Inc. (NYSE:CRL) offers drug discovery, non-clinical development, and safety…